webinar register page

Webinar banner
Oppenheimer Virtual Fireside Chat: Pulmonary Sarcoidosis (Interstitial Lung Disease) & New Treatment Options
Please join us on Monday, December 5th at 11:00 AM – 12:00 PM (ET) for a virtual Fireside Chat moderated by Hartaj Singh, Managing Director and Senior Analyst covering Biotechnology, at Oppenheimer & Co, Inc., with the President & Chief Executive Officer of aTyr Pharma Inc. (LIFE), Dr Sanjay S. Shukla, MD, joined by, Pulmonary Sarcoidosis (PS) expert, Dr. Peter Sporn, MD, to discuss Pulmonary Sarcoidosis (Interstitial Lung Disease) and New Treatment Options.

We are pleased to host the upcoming virtual fireside chat with management member aTyr Pharma (LIFE) President and Chief Executive Officer, Sanjay S. Shukla, M.D., M.S., joined by Pulmonary Sarcoidosis (PS) expert Dr. Peter Sporn; Dr. Sporn is a Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at the Feinberg School of Medicine, Northwestern University, whose research focuses on these clinical entities and on basic mechanisms of airway inflammation, airway remodeling, innate immunity and host defense in the lung. We will discuss Pulmonary Sarcoidosis current diagnosis, standard of care (SoC), treatment burden, and emerging treatment options. We are also interested in KOL’s opinion on aTyr’s efzofitimod Phase 1b/2a data in pulmonary sarcoidosis patients and the expectations for the pivotal trial, which was initiated this year.

Dec 5, 2022 11:00 AM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: deena.sullivan@opco.com.